Sakauye Kenneth M, Camp Cameron J, Ford Patricia A
Department of Geriatric Psychiatry, LSU Medical Center, New Orleans, Louisiana; Department of Woldenberg Center for Gerontological Studies, Touro Infirmary, New Orleans, Louisiana; Department of Psychology, University of New Orleans, Louisiana.
Am J Geriatr Psychiatry. 1993;1(1):82-84. doi: 10.1097/00019442-199300110-00011. Epub 2013 Jan 28.
Ten patients with probable Alzheimer's disease participated in an open-label study of buspirone for agitation. The starting dose of 15 mg/day was increased by 5 mg every week until maximal improvement or 60 mg/day was reached. A significant decrease in agitation scores occurred at an average dose of 35 mg/day.